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The extent of myocardial salvage after primary percutaneous
transluminal coronary angioplasty (PTCA) in acute myocardial
infarction (AMI) is variable and cannot be predicted on the basis
of either vessel patency or early regional wall motion assess
ment. The aim of this study was to evaluate the reliability of
microvascular integrity, as shown by myocardial contrast echocar-
diography (MCE), as an indicator of tissue salvage and a
predictor of late functional recovery, and to compare MCE with
the quantification of tracer activity in sestamibi perfusion imaging.
Methods: Twenty-sixpatientswithAMI who receivedsuccessful
treatment with primary PTCA were examined with MCE during
cardiac catheterization immediately before and after vessel
recanalization. Myocardial contrast effect was scored as 0
(absent), 0.5 (partial) or 1 (normal). Wall motion was assessed by
two-dimensional echocardiography on admission and 1 mo later
with a 16-segment model and 4-point score. Resting sestamibi
SPECT was collected within 1 wk after AMI. The risk area was
defined by MCE as the sum of the segments with no perfusion
(score 0) before PTCA. Myocardial viability was defined by MCE
as an increase in contrast score in the same segments after
PTCA and by sestamibi SPECT as a preserved tracer activity
(>60% of peak activity). The functional recovery after 1 mo
detected by two-dimensional echocardiography was the refer
ence standard for viability. Results: A total of 50 segments
showed perfusion defects before PTCA (risk area). Immediately
after PTCA, the MCE score increased in 44 of 50 segments,
whereas sestamibi SPECT showed preserved activity in 22 of 50
segments. After 1 mo, the wall motion score decreased in 22 of
50 segments (viable segments) and was unchanged in the
remaining 28 segments. Thus, MCE showed a sensitivity of 91%
and a specificity of 14% in detecting viable myocardium, whereas
sestamibi SPECT showed a lower sensitivity (68%) but a signifi
cantly higher specificity (75%; P < 0.00001).The positive predictive
values were 45% and 68% for MCE and SPECT (P < 0.005),
respectively, and the negative predictive values were 67% and
71%, respectively. On a patient basis, SPECT was more specific
(79% versus 21%; P < 0.01) and showed a higher overall
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predictive accuracy (88% versus 50%; P < 0.01) than MCE.
Conclusion: The demonstrationof microvascularintegrityby MCE
performed immediately after primary PTCA has a limited diagnos
tic value in predicting salvaged myocardium. Conversely, tracer
activity quantification in resting sestamibi SPECT performed in a
later stage is confirmed to be a reliable approach for recognizing
myocardial stunning and predicting functional recovery.
Key Words: myocardialcontrastechocardiography;acute myo
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JLn patients with acute myocardial infarction (AMI) and
early hospital admission, primary percutaneous transluminal
coronary angioplasty (PTCA) usually allows prompt restora
tion of coronary blood flow to the jeopardized myocardium.
However, the angiographie demonstration of vessel patency
after the procedure does not necessarily imply effective
reflow (1-3) or actual myocardial salvage within the in-
farcted area (3,4). Furthermore, because of myocardial
stunning, regional wall motion abnormalities persist, despite
early recanalization (5). Therefore, various imaging tech
niques have been proposed to assess the effectiveness of
myocardial reperfusion in acute infarction.
Two main approaches are currently used to this aim (5).
The first is based on the prediction of late functional
recovery of asynergic regions by means of their response to
inotropic stimuli, mainly by using low-dose dobutamine
echocardiography (6-8). The other is based on the demon
strated relationship between recognition of tissue viability in
dysfunctional segments and subsequent spontaneous recov
ery (6,9-13). The assessment of myocardial viability may be
performed with metabolic imaging with PET (6,10), but
myocardial perfusion imaging with single-photon tracers is
the more frequently used technique (9,11-13). In particular,
WmTc-sestamibi myocardial perfusion imaging has been
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extensively used in this field, mainly because of the possibil
ity to directly evaluate the extent of tissue salvage by comparing
pre-reperfusion and post-reperfusion images (11-13).
Recently, myocardial contrast echocardiography (MCE)
has been introduced as a new method to assess microvascu-
lar integrity (1-3,14-18). The demonstration of microvascu-
lar integrity within an infarcted area has been found to be a
requisite of tissue viability, and consequently, a possible
indirect sign of effective reperfusion and a potential predic
tor of late functional recovery (14-16). At present, the main
limitation to the widespread use of MCE is the need to inject
the contrast agent in the coronary artery. However, in the
setting of primary PTCA, which requires the execution of
left heart catheterization, this does not represent an obstacle
to the use of MCE. On the contrary, the possibility of
estimating the results of primary PTCA directly during the
same catheterization session would be a major advantage
over the above mentioned techniques that may be used with
some delay after vessel reopening (1,4).
Previous data suggested a good agreement between MCE
and sestamibi SPECT for the evaluation of myocardial
perfusion in chronic coronary artery disease (CAD) (79).
The aim of this study was to evaluate the diagnostic
reliability of microvascular integrity by MCE performed
immediately after vessel recanalization in detecting the
presence of effective tissue reperfusion in AMI treated by
primary PTCA and predicting late functional recovery of
stunned salvaged myocardium. Furthermore, we compared
MCE results with the assessment of myocardial viability
obtained from the quantification of tracer uptake in resting
sestamibi SPECT.
MATERIALS AND METHODS
Patient Population
The patient population included 26 patients with AMI (22 men,
4 women; mean age 57 Â±12 y) who were admitted to our coronary
care unit within 6 h of symptom onset (mean 137 Â±72 min, range
30-300 min) and referred to the catheterization laboratory for
emergency primary PTCA. In all patients, the diagnosis of AMI
was based on the presence of typical chest pain for >30 min
associated with >0.1 mV S-T segment elevation in at least two
contiguous electrocardiographs (ECG) leads. Other inclusion
criteria were total occlusion of the infarct-related artery, successful
primary PTCA (defined as thrombolysis in myocardial infarction
(TIMI] trial flow grade 3 and residual stenosis <30% of lumen
diameter) and willingness to participate in the study. Patients were
excluded in the case of clinical instability or cardiogenic shock and
if the echocardiographic window was inadequate for satisfactory
visualization of the entire left ventricular wall. In particular, 2 of 28
otherwise potentially eligible patients had to be excluded from the
study cohort according to this last criterion.
Study Protocol
The study protocol included the acquisition of MCE (a) during
acute coronary occlusion, immediately after diagnostic coronary
angiography and (b) immediately after successful completion of
primary PTCA. Two-dimensional echocardiography to evaluate
regional wall motion was performed at patient admission and was
repeated 1 mo later to assess the functional outcome. Resting
sestamibi SPECT was performed at a mean of 6.5 Â±1.2 d (range
4â€”9d) after index infarction. The ethics committee of our institu
tion approved the study protocol.
Myocardial Contrast Echocardiography
The studies were collected immediately before PTCA and after
completion of the procedure with the patients lying in the supine
position, using commercially available imaging systems (SSD-830
2.5- and 3.5-MHz transducers [Aloka Co., Tokyo, Japan) and
Sonos 2500 2.5-MHz transducer [Hewlett-Packard Co., Andover,
MA]). MCE was performed by injecting 3 mL hand-agitated
iopamidol, followed by a 3-mL saline flush directly into the left
main and right coronary ostia through the standard catheter used for
diagnostic angiography (14,20). The echocardiographic view that
best visualized the most asynergic wall was identified before
contrast medium injection, the most appropriate gain setting was
chosen and both were kept unchanged throughout the study. Image
collection began immediately before contrast medium injection and
ended approximately 3 min later. All images were recorded on
videotape for later analysis. Continuous 12-Iead ECG monitoring
was performed during the whole procedure.
Two-Dimensional Echocardiography
Regional wall motion was evaluated at the time of admission in
the coronary care unit and 1 mo later. In both instances, the patients
were studied in left lateral decubitus, with a commercially available
scanner (Aloka SSD 870 2.5- and 3.5-MHz transducers). All
standard views were acquired and recorded on videotape for
off-line evaluation.
Sestamibi SPECT
The tracer dose was 20-25 mCi (740-925 MBq) and was
injected into the resting patient lying supine. Images were collected
60 min later with a single-head, large-field-of-view tomographic
gamma camera equipped with an ultra-high-resolution collimator,
and with a 20% window centered on the 140-keV photopeak of
MraTc. Sixty projections of 20 s each were acquired. Image
reconstruction was performed with filtered backprojection. No
attenuation or scatter correction was used. The transaxial slices
were realigned along the heart axis. For the quantitative evaluation
of SPECT images, the short-axis slices from the first with apical
activity to the last with activity at the base were used. Their count
profiles were generated by computer software and plotted onto a
two-dimensional volume-weighted polar map, which was then
divided into 16 segments, matching the echocardiographic ones.
With an automated procedure, segment tracer activity was calcu
lated as the total of the normalized counts of the pixels included
within the segment divided by the pixel number. The segment with
maximal activity was then normalized to 100 and the activity of the
other segments was expressed as a percentage of the peak activity
segment (21).
Data Analysis
For the analysis of the echocardiographic images, a 16-segment
model was adopted (22). Anterior and inferior infarcÃ¬zones were
defined, both including 9 segments (7). Taking into account the
infarct-related vessel, the appropriate infarcÃ¬zone for each patienl
was identified. In each examined segment within the infarcÃ¬zone,
the myocardial conlrasl effecl was scored visually by ihree blinded
observers, using a 3-poinl scheme: 0 = no visible conlrasl effecl,
i.e., no appareni perfusion; 0.5 = palchy conlrasl effect or
enhancement of the epicardial layer only, i.e., reduced perfusion;
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and 1 = homogeneous contrast effect in the entire myocardial wall,
i.e., normal perfusion (15,18). In case of disagreement between the
observers, consensus was established by the majority. Wall motion
was assessed with a 4-point scoring scheme: 1 = normal wall
motion, 2 = hypokinesia, 3 = akinesia and 4 = dyskinesia (22).
Two experienced observers blinded to all other information per
formed the scoring. Discrepancies were resolved by consensus
agreement. Previous studies in our laboratory demonstrated high
levels of intraobserver and interobserver reproducibility of echocar-
diographic scoring both as regards MCE and wall motion assess
ment (23).
Criteria for Myocardial Viability
The perfusion risk area was defined by the segments with absent
perfusion (score 0 in pre-PTCA MCE) included within the infarcÃ¬
zone. Only the segments included within the perfusion risk area
were considered for follow-up evaluation of regional function and
a significant wall motion improvement was defined as a s l point
decrease in segment wall motion score between admission and
follow-up. For the patient analysis, a patient was considered
improved on follow-up echocardiography if the wall motion score
decreased s l point in at least 2 contiguous segments. For the MCE
definition of myocardial viability, a segment was considered to be
viable if it showed either grade I or grade 0.5 contrast effect in the
post-PTCA study. On a patient basis, MCE was considered to
demonstrate viability if at least half of the segments included in the
patient's perfusion risk area showed improved perfusion in the
post-PTCA study. For the SPECT definition of myocardial viabil
ity, a percentage activity >60% of peak was required (24,25). For
the patient analysis, the mean activity value in the segments
included within the perfusion risk area was considered by using the
same >60% cutoff.
Statistical Analysis
Data are expressed as appropriate as the mean Â±SD. The
comparisons of continuous variables within and between groups
were performed with 2-way analysis of variance (ANOVA) for
repeated measures, with the Tukey post-hoc test. The comparison
between groups of ordinal variables was made with nonparametric
ANOVA (Kruskal-Wallis rank test). The comparison of proportion
was made with the Fisher exact test. P value < 0.05 was considered
statistically significant.
RESULTS
General Findings
The ECG changes of AMI involved the anterior leads in
14 patients and the inferior leads in 12. The infarct-related
artery was the left anterior descending in 14 patients, the left
circumflex in 2 and the right coronary artery in 10 patients. A
total of 15 patients were affected by single-vessel CAD, 10
by two-vessel CAD and 1by three-vessel CAD. The echocardio-
graphic left ventricular ejection fraction on admission was
43% Â±10%. Primary PTCA was successful in all patients
and was performed without complications. The peak cre
atine phosphokinase release reached 3162 Â±1986 IU.
Myocardial Contrast Echocardiography During
Coronary Occlusion
Because the analysis of MCE images was limited to one
cross-sectional view, only 96 segments among the 234
infarcÃ¬zone segments could be evaluated by MCE during
coronary occlusion. Before PTCA, 40 segments showed a
homogeneous contrast effect (score 1), 6 segments showed a
partial contrast effect (score 0.5) and 50 no apparent contrast
effect (score 0). All 50 segments were considered to
constitute the area of myocardium at risk and all showed
wall motion abnormalities at the two-dimensional echocardi
ography on admission (wall motion score 3 Â±0.3, range
2â€”4).Two patients did not show any segment with score 0
before PTCA, but only segments with partial contrast effect.
The remaining 24 patients had 1-3 segments with score 0,
with a mean of 1.9 Â±1.
Myocardial Contrast Echocardiography
After Primary PTCA
Immediately after completion of primary PTCA, a homo
geneous contrast effect was observed in 34 segments. In 10
additional segments within the risk area, MCE showed an
incomplete contrast effect after PTCA. Thus, a total of 44
segments were defined viable by post-PTCA MCE. Finally,
6 segments did not show any apparent contrast enhancement
despite the recanalization of the infarct-related artery (Fig. 1).
Risk area segments
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FIGURE 1. Diagram shows myocardial
contrast echocardiography (MCE) score
changes in perfusion risk area segments
and their relationship with functional out
come assessed using wall motion (WM)
evolution on follow-up (F-U) echocardiogra
phy.
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Of the 24 patients with perfusion defects during coronary
occlusion, 17 showed a significant improvement in myocar-
dial perfusion after PTCA, whereas 7 did not show any
significant change in MCE findings.
Sestamibi SPECT
The mean tracer activity in the 96 segments evaluated
with MCE was 65% Â±19%. No segments with abnormal
sestamibi uptake were observed outside the infarcÃ¬zone. In
the 50 segments constituting the MCE risk area, the tracer
activity was 61% Â± 20% (range 23.5%-100%). More
specifically, the tracer activity was >60% in 22 segments
(defined as viable) and less than this threshold in 28
segments. On a patient basis, 13 patients showed a mean
activity in the perfusion risk area >60%, and 11 a value
below this cutoff.
Follow-up Evaluation
One month after AMI, all patients were catheterized and
all showed a patent infarct-related artery. The echocardio-
graphic left ventricular ejection fraction was 50% Â±11%
(P < 0.01 versus admission). On the follow-up echocardio-
gram, 22 segments of the 50 included in the perfusion risk
area showed functional recovery, whereas 28 had an un
changed wall motion abnormality (Fig. 1). In terms of
patients, 10 showed a recovery in wall motion and 14 did
not.
Early Myocardial Contrast Echocardiography
and Myocardial Viability
The post-PTCA MCE scoring was not significantly differ
ent in the group of viable versus that of nonviable segments
(P = 0.89). Table 1 summarizes the results of the segment
analysis. On the basis of the above data, MCE performed
shortly after primary PTCA showed a sensitivity of 91 % and
a specificity of 14% in detecting viable segments. The
positive and negative predictive values of MCE were 45%
and 67%, respectively. On a patient basis, MCE had a
specificity of 21% and an overall predictive accuracy of 50%
(Table 2).
Sestamibi Imaging and Myocardial Viability
A significant difference was observed in the sestamibi
activity between the segments, which improved after 1 mo
TABLE 1
Diagnostic Reliability of Reflow in Myocardial Contrast
Echocardiography (MCE) and of Activity >60% in Sestamibi
SPECT to Identify Segments with Stunned Myocardium
Within Perfusion Risk Area
MCE Sestamibi SPECT
Segments % Segments
SensitivitySpecificityPositive
predictivevalueNegative
predictivevalueAccuracy20/224/2820/444/624/50911445674815/2221/2815/2221/2836/506875687172
TABLE 2
Diagnostic Reliability of Reflow in Myocardial Contrast
Echocardiography (MCE) and of Activity >60% in Sestamibi
SPECT to Identify Patients with Stunned Myocardium
Within Perfusion Risk Area
MCESensitivity
Specificity
Positive predictive value
Negative predictive value
AccuracyPatients9/10
3/14
9/20
3/4
12/24%90
21
45
75
50Sestamibi
SPECTPatients10/10
11/14
10/13
11/11
21/24%100
79
77100
88
(viable) and those permanently asynergic: (71.8% Â±17.6%
versus 51.5% Â±17%, respectively; P < 0.0005) (Fig. 2).
The results of segment analysis are shown in Table 1 and
those of patient analysis in Table 2. Sestamibi SPECT
showed a sensitivity of 68%, a specificity of 75% (P <
0.00001 versus MCE) and an overall accuracy of 72% (P <
0.03 versus MCE) (Fig. 3). The positive and negative
predictive values of SPECT were 68% and 71%, respec
tively, and the former was higher than that of MCE (P <
0.005) (Fig. 3). On a patient basis, delayed SPECT was more
specific (79%; P < 0.01) and showed a higher overall
predictive accuracy (88%; P < 0.01) than MCE (Fig. 4). We
also tested the use of the >50% threshold to define segment
viability: In segment analysis this increased SPECT sensitiv
ity to the same level of MCE (91%) and decreased its
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FIGURE 2. Scatterplot of sestamibi activity in perfusion risk
area segments divided according to presence or absence of
functional recovery in follow-up echocardiography. Individual
data points and mean Â±SD are shown.
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Sensitivity Specificity PPV NPV Accuracy
FIGURE 3. Bar graph compares on seg
ment basis results of MCE and those of
sestamibi SPECT in identification of myocar-
dial salvage.
specificity to 57% (P < 0.002 versus MCE), so that overall
accuracy did not change.
DISCUSSION
MCE has been recently introduced as a very attractive
method for the evaluation of myocardial perfusion and the
demonstration of microvascular integrity (1,14-18,26). MCE
is based on the visualization of the contrast effect produced
during the passage of an intravascular ultrasonic contrast
medium, such as microbubbles. through the ventricular wall
(26). The presence of a contrast effect has been demon
strated to depict the spatial distribution of microvascular
perfusion and therefore implies preserved microvascular
integrity (1-3,14-18). In the setting of AMI treated with
reperfusion with either thrombolysis or primary PTCA,
MCE allowed the identification of the so-called no-reflow
phenomenon, which accounts for the discrepancy between
the achievement of vessel patency and tissue salvage (1^4).
This phenomenon has been demonstrated in a variable, but
usually low proportion of patients undergoing primary
PTCA, and, accordingly, the absence of perfusion in MCE
has been shown to imply the lack of functional recovery of
the involved region (1,3,16,18). Conversely, other data
suggest the possibility of identifying the presence of cellular
Sensitivity Specificity PPV NPV Accuracy
FIGURE 4. Bar graphcompareson patient
basis results of MCE and those of sestamibi
SPECT in identification of myocardial sal
vage.
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integrity and, thus, of myocardial salvage in patients with
myocardial infarction by means of the recognition of
microvascular integrity obtained by using MCE. In particu
lar, Ragosta et al. (15) demonstrated the relationship be
tween microvascular and myocellular integrity in patients
studied during the subacute phase of myocardial infarction.
Agati et al. (76) reported that residual perfusion within
segments with abnormal function may imply a further
reduction in ventricular dysfunction in a later phase. Lim et
al. (17). however, by studying patients both before and after
recanalization, observed that many of those with contrast
enhancement immediately after reperfusion did not show
signs of myocardial salvage in the long term. Similarly,
Camarano et al. (18) registered the absence of functional
recovery in almost half of the segments with homogeneous
contrast effect after previous myocardial infarction. There
fore, although the unfavorable implications of absent perfu
sion after vessel reopening appear quite established, the
meaning of perfusion restoration seems more uncertain.
At present, the most important obstacle to the use of MCE
is the need for intracoronary injection of the contrast
medium. This limitation is not applicable to the use of MCE
in combination with primary PTCA. On the contrary, the
possibility to obtain immediate information about tissue
perfusion without the need of additional tests would be
highly desirable, because the currently used methods to
detect salvaged myocardium are generally performed in a
later phase after the recanalization procedure (1,4). Previous
data from our group, however, suggest that low-dose
dobutamine echocardiography is significantly more effective
than MCE for the prediction of functional recovery of infarcÃ¬
areas in patients who received treatment with primary PTCA
(23). The different signal explored by the two techniques
(contractile reserve versus microvascular integrity) could
partly explain these discrepancies. Regarding the compari
son of MCE with myocardial perfusion scintigraphy, prior
data showed a good correlation between MCE and sestamibi
SPECT in patients with chronic CAD studied at rest,
indicating the relative equality of the two methods in
depicting resting myocardial perfusion (19). However, differ
ences between the two methods could be expected in other
settings, taking into account that MCE agents are pure flow
tracers, whereas sestamibi uptake is also significantly influ
enced by myocardial viability (27-29). In this study, we
tested the reliability of MCE for the detection of stunned
salvaged tissue and the prediction of late functional recovery
comparing MCE demonstration of reflow with the evalua
tion of viability according to the quantification of sestamibi
activity in perfusion SPECT.
According to our results, an absent contrast effect in MCE
performed immediately after primary PTCA was followed
by the lack of functional recovery in most segments.
Conversely, the detection of reperfusion in post-PTCA MCE
did not necessarily imply the presence of myocardial
salvage, as shown by the very low predictive value of the
positive result. These unsatisfactory results were fully
replicated when the analysis was performed on a patient
instead of on a segment basis. Regarding the comparison
with sestamibi perfusion imaging, both the segment and the
patient analysis showed a significant superiority of the latter
technique over MCE in terms of both specificity and overall
accuracy, without significant loss in sensitivity. These data
suggest that the demonstration of reperfusion and microvas
cular integrity obtained immediately after primary PTCA
with MCE does not imply the subsequent detection of
activity levels in the viability range on sestamibi perfusion
imaging and, more importantly, late functional recovery.
Thus, the early finding of preserved microvascular integrity
cannot always be assimilated to the proof of ultimately
preserved cellular integrity.
With regard to sestamibi SPECT, the data of this study
support its use for the assessment of tissue viability after
AMI (5,30). More specifically, the execution of a single
post-revascularization study, including the assessment of
tracer uptake and the use of a threshold value to differentiate
viable from nonviable myocardium, appears to be an easy
and effective approach to the recognition of stunned myocar
dium in asynergic segments and to the prediction of a
patient's functional outcome (25,30). Unlike the execution
of both pre- and post-revascularization imaging, this ap
proach can be easily performed in almost every nuclear
medicine laboratory (30). Furthermore, the effectiveness of
a threshold about 60% of peak activity confirms what has
been shown in patients who were studied for myocardial
viability in chronic CAD (21,24).
Various possible explanations can be invoked to account
for the low accuracy of MCE. Certainly, the time interval
between MCE and sestamibi SPECT in our protocol pre
cludes a straight comparison of the two techniques in terms
of tissue perfusion assessment. The possible interference of
reperfusion hyperemic flow on MCE performed immedi
ately after vessel reopening and in the absence of flow-
limiting residual obstruction is probably an important factor
to explain the low specificity of MCE (31,32). More in
general, the possibility of a temporal dissociation between
microvascular and cellular damage should be considered
(33,34). Recently, a possible role of intramyocardial hemor
rhage was suggested to explain the delayed appearance of
MCE defects and the lack of functional improvement in
patients with MCE evidence of reflow immediately after
primary PTCA (35). The availability in the near future of
contrast agents that can be injected intravenously will solve
many of these problems, because MCE might easily be
repeated after PTCA, when the hyperemic response has
subsided and both microvascular and cellular damage have
reached their final and full extent.
Subsequent evidence of preserved sestamibi uptake and
late functional recovery was seen in segments (and patients)
without MCE signs of early effective reperfusion. This is
another important observation of this study, but one that is
more difficult to interpret. A possible explanation might be
that flow restoration could be slower in some cases (36-38).
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Also in this case, the availability of intravenous contrast
agents and the possibility to perform repeated evaluations
will probably improve the diagnostic power of MCE.
Technical problems could also be invoked, however, given
the need to perform the MCE study acquisition with the
patient lying supine and the limited number of adequately
visualized segments.
The small patient population and the scanty number of
evaluated segments are the first major limitations of this
study. Another important limitation derives from the timing
of MCE and SPECT in this protocol. We already noted that
the time interval between the two investigations precludes
their direct comparison in terms of perfusion assessment. On
the other hand, both methods were applied at their most
convenient time points, i.e., MCE immediately during the
PTCA catheterization session and SPECT in a later phase,
when patient conditions are stable and execution of radionu-
clide studies is simplest. In this study, the rationale of the use
of both methods was not to identify which patients should
undergo PTCA, but to evaluate the effectiveness of the
procedure in terms of functional recovery. In particular, we
did not use sestamibi SPECT to directly identify the
salvaged area through the comparison between pre- and
post-revascularization images, as previously performed by
our group and by other investigators (11-13). However, both
the rationale of a single post-revascularization study per
formed immediately after thrombolysis (39) and the high
informative content of the pre-discharge assessment of
myocardial perfusion (25,30) have already been indicated.
The late execution of post-revascularization scintigraphy is
reasonable to obtain the most reliable estimate of final
infarcÃ¬size and the best prediction of the patient's final
outcome (30). At last, delayed perfusion imaging appears
particularly acceptable in those patients in whom further
revascularization procedures cannot be considered because
of the optimal angiographie result of primary PTCA.
Therefore, the comparison of MCE and sestamibi SPECT in
this protocol makes sense in terms of clinical usefulness and
reliability. Naturally, no data can be derived from this study
about the role of sestamibi SPECT in patients with acute
chest pain. The very early acquisition time of the post-PTCA
MCE images was also already mentioned as a possible
limitation because of the problems related to the post-
reperfusion hyperemia. The administration of dipyridamole
to increase coronary flow in the other territories and,
therefore, to compensate for the hyperemia in the infarcted
region has been proposed (4,40). So far, however, there are
no data to support the real usefulness of this approach, which
may also pose hazards and logistic complications. Further
more, most recent data based on intracoronary Doppler flow
measurements and on PET imaging in patients who received
treatment with primary PTCA indicate that coronary reserve
may be depressed even in the non-infarct-related vessels
(41). This circumstance could limit the potential usefulness
of dipyridamole administration to counterbalance the reper-
fusion hyperemia of the infarcÃ¬region. The difficulty of
perfectly matching the segments in MCE and two-
dimensional echocardiography was also mentioned. It is
hard to believe, however, that these difficulties were larger
than those potentially existing in the comparison between
two different imaging modalities such as two-dimensional
echocardiography and SPECT (79), and which were cer
tainly also present in ihis sludy cohort. Furthermore, il musi
be considered lhal MCE is also affecled by the common
limitations to echocardiography in patients with suboptimal
ultrasonic window. The adopted threshold for Ihe definilion
of viability in sestamibi images was arbitrary, allhough
supported by previous studies (24,25). The small dimensions
of the study sample did not allow a systemalic analysis of Ihe
mosl optimal cutoff value. However, when another widely
adopted threshold was considered (>50% of peak activily),
Ihe superiority of SPECT over MCE was maintained, with
an increase in sensitivity, a decrease in specificity and the
same overall accuracy as using the >60% cutoff. Finally, it
is undeniable that the detection of functional recovery at the
1-mo follow-up control is just an imperfect reference
standard for myocardial viability: More delayed improve
ment cannot be excluded, and other parameters of preserved
viabilily, such as prevention of ventricular remodeling,
could be considered (42,43).
CONCLUSION
This study suggests that early demonstration of reflow in
MCE performed during the same catheterization session has
a limited value as a routine diagnostic tool to assess the
effectiveness of primary PTCA in terms of tissue salvage.
This is confirmed by comparing its results with the later
quantification of myocardial viability achieved using ses
tamibi SPECT. With regard to this last technique, this study
supports its role for the evaluation of myocardial viability in
AMI. In particular, the quantitative assessment of tracer
uptake using an activity threshold is able to give a useful
estimate of myocardial viability and an effective prediction
of subsequent functional recovery of stunned myocardium
independently of the comparison of pre- and post-revascular
ization images.
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